Tarsier Pharma
Novel Treatments for Autoimmune Inflammatory Ocular Diseases
Active
Seed
Startup
Zikhron Ya'akov
Founded 2016-01
Tarsier Pharma is a late-clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune inflammatory ocular diseases. The TRS Platform Technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases. It is currently being devel…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$5.7M
Employees12
Founded2016-01
HQZikhron Ya'akov
Crunchbasetarsius-pharma-ltd
Patents1
Confidence98
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals